BackAlexion Pharmaceuticals Overview

Alexion Pharmaceuticals Research & Development

Research & Development expenses for ALXN.

Quarterly R&D Expenses

$289.10M
↑ 43.9% YoY

As of Mar 31, 2021

Annual R&D Expenses (TTM)

$1.09B
↑ 22.46% YoY

Trailing 12 months ending Mar 31, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin